{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,24]],"date-time":"2026-01-24T13:47:09Z","timestamp":1769262429297,"version":"3.49.0"},"reference-count":24,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T00:00:00Z","timestamp":1769126400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Pre-existing comorbidities prior to allogeneic hematopoietic stem cell transplantation (HSCT), significantly affects outcomes. Prior hepatic impairment is included in classic prognostic scores like HCT-CI, without taking into consideration modern assessment techniques such as liver stiffness (LS) measurement. We aimed to evaluate the value of LS using Fibroscan (FS) to predict transplant outcomes and hepatic complications in patients undergoing allo-HSCT using post-transplant cyclophosphamide (PTCY) for graft-versus-host disease (GVHD) prophylaxis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We conducted a single-center, prospective, observational study to evaluate the utility of LS measurement performed prior to transplantation and on day +14 to predict transplant outcomes, between October 2021 and March 2024. ROC curves were used to identify cut-off points for LS values for the development of hepatotoxicity, veno-occlusive disease (VOD), and hepatic acute and chronic GVHD. Logistic regression was used to analyse the impact of LS on overall survival (OS), event-free survival (EFS), non-relapse mortality (NRM) and graft-versus-host-disease and relapse-free survival (GRFS) .<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>One hundred eight patients were included. Median follow-up was 12.5 months. OS, EFS, GRFS, cumulative incidence of relapse and NRM at 12-months were 75%, 68%, 55%, 22% and 9%, respectively. Cumulative incidences of grade II-IV acute GVHD at day 180 and moderate-severe chronic GVHD at 12 months were 14% and 12%, respectively. Five patients (4.6%) developed VOD. LS variation (FS\u0394) from baseline LS to day +14 was significantly increased in those patients who developed VOD compared to those who did not (p=0.048; AUROC 0.8). Logistic regression univariate analysis showed FS+14&amp;gt;6KPa to be predictive for worse OS and EFS (p&amp;lt;0.05). Multivariate analysis found FS+14&amp;gt;6 KPa to be predictive for worse EFS.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion<\/jats:title>\n                    <jats:p>In our experience, increase in LS between baseline and day +14 was predictive for VOD. In addition, a measurement of FS+14&amp;gt;6Kpa was predictive for the outcome of allo-HSCT, with an independently predictive value for worse EFS. Thus, FS+14&amp;gt;6 KPa should be considered in future prognostic models used for PTCY-based HSCT.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fimmu.2025.1699219","type":"journal-article","created":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T06:48:37Z","timestamp":1769150917000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Prognostic value of liver stiffness measurement for complications after allogeneic transplant with post-transplant cyclophosphamide"],"prefix":"10.3389","volume":"16","author":[{"given":"Rebeca","family":"Bail\u00e9n","sequence":"first","affiliation":[{"name":"Department of Hematology and Hemotherapy, Hospital General Universitario Gregorio Mara\u00f1\u00f3n","place":["Madrid, Spain"]},{"name":"Instituto de Investigaci\u00f3n Sanitaria Gregorio Mara\u00f1\u00f3n (IiSGM)","place":["Madrid, Spain"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manuel","family":"Fern\u00e1ndez-Villalobos","sequence":"additional","affiliation":[{"name":"Department of Hematology and Hemotherapy, Hospital General Universitario Gregorio Mara\u00f1\u00f3n","place":["Madrid, Spain"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sonia","family":"Alonso","sequence":"additional","affiliation":[{"name":"Instituto de Investigaci\u00f3n Sanitaria Gregorio Mara\u00f1\u00f3n (IiSGM)","place":["Madrid, Spain"]},{"name":"Department of Gastroenterology, Hospital General Universitario Gregorio Mara\u00f1\u00f3n","place":["Madrid, Spain"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ignacio","family":"G\u00f3mez-Centuri\u00f3n","sequence":"additional","affiliation":[{"name":"Department of Hematology and Hemotherapy, Hospital General Universitario Gregorio Mara\u00f1\u00f3n","place":["Madrid, Spain"]},{"name":"Instituto de Investigaci\u00f3n Sanitaria Gregorio Mara\u00f1\u00f3n (IiSGM)","place":["Madrid, Spain"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paula","family":"Fern\u00e1ndez-Caldas","sequence":"additional","affiliation":[{"name":"Department of Hematology and Hemotherapy, Hospital General Universitario Gregorio Mara\u00f1\u00f3n","place":["Madrid, Spain"]},{"name":"Instituto de Investigaci\u00f3n Sanitaria Gregorio Mara\u00f1\u00f3n (IiSGM)","place":["Madrid, Spain"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luc\u00eda","family":"Castilla","sequence":"additional","affiliation":[{"name":"Department of Hematology and Hemotherapy, Hospital General Universitario Gregorio Mara\u00f1\u00f3n","place":["Madrid, Spain"]},{"name":"Instituto de Investigaci\u00f3n Sanitaria Gregorio Mara\u00f1\u00f3n (IiSGM)","place":["Madrid, Spain"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda Jos\u00e9","family":"Ll\u00e1cer","sequence":"additional","affiliation":[{"name":"Department of Hematology and Hemotherapy, Hospital General Universitario Gregorio Mara\u00f1\u00f3n","place":["Madrid, Spain"]},{"name":"Instituto de Investigaci\u00f3n Sanitaria Gregorio Mara\u00f1\u00f3n (IiSGM)","place":["Madrid, Spain"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adriana","family":"Ahumada","sequence":"additional","affiliation":[{"name":"Instituto de Investigaci\u00f3n Sanitaria Gregorio Mara\u00f1\u00f3n (IiSGM)","place":["Madrid, Spain"]},{"name":"Department of Gastroenterology, Hospital General Universitario Gregorio Mara\u00f1\u00f3n","place":["Madrid, Spain"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlos","family":"Iniesta","sequence":"additional","affiliation":[{"name":"Instituto de Investigaci\u00f3n Sanitaria Gregorio Mara\u00f1\u00f3n (IiSGM)","place":["Madrid, Spain"]},{"name":"Department of Gastroenterology, Hospital General Universitario Gregorio Mara\u00f1\u00f3n","place":["Madrid, Spain"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diego","family":"Rinc\u00f3n","sequence":"additional","affiliation":[{"name":"Instituto de Investigaci\u00f3n Sanitaria Gregorio Mara\u00f1\u00f3n (IiSGM)","place":["Madrid, Spain"]},{"name":"Department of Gastroenterology, Hospital General Universitario Gregorio Mara\u00f1\u00f3n","place":["Madrid, Spain"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cristina","family":"Mu\u00f1oz","sequence":"additional","affiliation":[{"name":"Department of Hematology and Hemotherapy, Hospital General Universitario Gregorio Mara\u00f1\u00f3n","place":["Madrid, Spain"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Santiago","family":"Sabell","sequence":"additional","affiliation":[{"name":"Department of Hematology and Hemotherapy, Hospital General Universitario Gregorio Mara\u00f1\u00f3n","place":["Madrid, Spain"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diego","family":"Carbonell","sequence":"additional","affiliation":[{"name":"Department of Hematology and Hemotherapy, Hospital General Universitario Gregorio Mara\u00f1\u00f3n","place":["Madrid, Spain"]},{"name":"Instituto de Investigaci\u00f3n Sanitaria Gregorio Mara\u00f1\u00f3n (IiSGM)","place":["Madrid, Spain"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Javier","family":"Anguita","sequence":"additional","affiliation":[{"name":"Department of Hematology and Hemotherapy, Hospital General Universitario Gregorio Mara\u00f1\u00f3n","place":["Madrid, Spain"]},{"name":"Instituto de Investigaci\u00f3n Sanitaria Gregorio Mara\u00f1\u00f3n (IiSGM)","place":["Madrid, Spain"]},{"name":"Department of Medicine, Universidad Complutense de Madrid","place":["Madrid, Spain"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ram\u00f3n","family":"Garc\u00eda-Sanz","sequence":"additional","affiliation":[{"name":"Department of Hematology and Hemotherapy, Hospital General Universitario Gregorio Mara\u00f1\u00f3n","place":["Madrid, Spain"]},{"name":"Instituto de Investigaci\u00f3n Sanitaria Gregorio Mara\u00f1\u00f3n (IiSGM)","place":["Madrid, Spain"]},{"name":"Department of Medicine, Universidad Complutense de Madrid","place":["Madrid, Spain"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rafael","family":"Ba\u00f1ares","sequence":"additional","affiliation":[{"name":"Instituto de Investigaci\u00f3n Sanitaria Gregorio Mara\u00f1\u00f3n (IiSGM)","place":["Madrid, Spain"]},{"name":"Department of Gastroenterology, Hospital General Universitario Gregorio Mara\u00f1\u00f3n","place":["Madrid, Spain"]},{"name":"Department of Medicine, Universidad Complutense de Madrid","place":["Madrid, Spain"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mi","family":"Kwon","sequence":"additional","affiliation":[{"name":"Department of Hematology and Hemotherapy, Hospital General Universitario Gregorio Mara\u00f1\u00f3n","place":["Madrid, Spain"]},{"name":"Instituto de Investigaci\u00f3n Sanitaria Gregorio Mara\u00f1\u00f3n (IiSGM)","place":["Madrid, Spain"]},{"name":"Department of Medicine, Universidad Complutense de Madrid","place":["Madrid, Spain"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2026,1,23]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1038\/s41409-022-01691-w","article-title":"Indications for haematopoietic cell transplantation for haematological diseases, solid tumours and immune disorders: current practice in Europe, 2022","author":"Snowden","year":"2022","journal-title":"Bone Marrow Transplant"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2004.11.018","article-title":"Prospective comparison of transient elastography, Fibrotest, APRI, and liver biopsy for the assessment of fibrosis in chronic hepatitis C","volume":"128","author":"Cast\u00e9ra","year":"2005","journal-title":"Gastroenterology"},{"key":"B3","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1016\/j.jhep.2017.02.003","article-title":"Non-invasive evaluation of portal hypertension using ultrasound elastography","volume":"67","author":"Berzigotti","year":"2017","journal-title":"J Hepatol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1038\/bmt.2016.320","article-title":"Usefulness of liver stiffness measurement in predicting hepatic veno-occlusive disease development in patients who undergo HSCT","volume":"52","author":"Colecchia","year":"2017","journal-title":"Bone Marrow Transplant"},{"key":"B5","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1016\/j.bbmt.2019.01.019","article-title":"Liver stiffness measurement allows early diagnosis of veno-occlusive disease\/sinusoidal obstruction syndrome in adult patients who undergo hematopoietic stem cell transplantation: results from a monocentric prospective study","volume":"25","author":"Colecchia","year":"2019","journal-title":"Biol Blood Marrow Transplant"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1038\/s41409-025-02570-w","article-title":"Diagnostic accuracy of liver stiffness measurement for the diagnosis of veno-occlusive disease\/sinusoidal obstruction syndrome after hematopoietic stem cell transplantation (HSCT), the ELASTOVOD STUDY: an investigator-initiated, prospective, multicentre diagnostic clinical trial","volume":"60","author":"Ravaioli","year":"2025","journal-title":"Bone Marrow Transplant"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1038\/bmt.2012.113","article-title":"Non-invasive transient elastography for the prediction of liver toxicity following hematopoietic SCT","volume":"48","author":"Auberger","year":"2013","journal-title":"Bone Marrow Transplant"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1038\/bmt.2014.61","article-title":"Value of liver elastography and abdominal ultrasound for detection of complications of allogeneic hemopoietic SCT","volume":"49","author":"Karlas","year":"2014","journal-title":"Bone Marrow Transplant"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2019.245407","article-title":"Elastography improves accuracy of early hepato-biliary complications diagnosis after allogeneic stem cell transplantation","volume":"106","author":"Debureaux","year":"2020","journal-title":"haematol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1038\/s41409-019-0464-x","article-title":"Predicting hepatic complications of allogeneic hematopoietic stem cell transplantation using liver stiffness measurement","volume":"54","author":"Karlas","year":"2019","journal-title":"Bone Marrow Transplant"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1038\/s41409-024-02288-1","article-title":"Liver stiffness measurements predict Sinusoidal Obstructive Syndrome after hematopoietic stem cell transplantation","volume":"59","author":"Davidov","year":"2024","journal-title":"Bone Marrow Transplant"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2013.53.8157","article-title":"Comorbidity-age index: A clinical measure of biologic age before allogeneic hematopoietic cell transplantation","volume":"32","author":"Sorror","year":"2014","journal-title":"J Clin Oncol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2020.04.013","article-title":"Current use of and trends in hematopoietic cell transplantation in the United States","volume":"26","author":"D\u2019Souza","year":"2020","journal-title":"Biol Blood Marrow Transplant"},{"key":"B14","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1016\/j.jtct.2022.01.020","article-title":"Post-transplantation cyclophosphamide after HLA identical compared to haploidentical donor transplant in acute myeloid leukemia: A study on behalf of GETH-TC","volume":"28","author":"Bail\u00e9n","year":"2022","journal-title":"Transplant Cell Ther"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2215943","article-title":"Post-transplantation cyclophosphamide-based graft-versus-host disease prophylaxis","volume":"388","author":"Bola\u00f1os-Meade","year":"2023","journal-title":"N Engl J Med"},{"key":"B16","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1038\/s41409-025-02514-4","article-title":"The impact of individual comorbidities in transplant recipients receiving post-transplant cyclophosphamide","volume":"60","author":"Spyridonidis","year":"2025","journal-title":"Bone Marrow Transplant"},{"key":"B17","doi-asserted-by":"publisher","first-page":"blood","DOI":"10.1182\/blood-2014-01-552984","article-title":"Validation and refinement of the disease risk index for allogeneic stem cell transplantation: a study from the CIBMTR","author":"Armand","year":"2014","journal-title":"Blood"},{"key":"B18","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.bbmt.2015.09.001","article-title":"International, multicenter standardization of acute graft-versus-host disease clinical data collection: A report from the mount sinai acute GVHD international consortium","volume":"22","author":"Harris","year":"2016","journal-title":"Biol Blood Marrow Transplant"},{"key":"B19","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1016\/j.bbmt.2014.12.001","article-title":"National institutes of health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. The 2014 diagnosis and staging working group report","volume":"21","author":"Jagasia","year":"2015","journal-title":"Biol Blood Marrow Transplant"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1038\/bmt.2016.130","article-title":"Revised diagnosis and severity criteria for sinusoidal obstruction syndrome\/veno-occlusive disease in adult patients: a new classification from the European Society for Blood and Marrow Transplantation","volume":"51","author":"Mohty","year":"2016","journal-title":"Bone Marrow Transplant"},{"key":"B21","unstructured":"Common terminology criteria for adverse events (CTCAE)\n          \n          2017"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2021.05.025","article-title":"EASL Clinical Practice Guidelines on non-invasive tests for evaluation of liver disease severity and prognosis \u2013 2021 update","volume":"75","author":"Berzigotti","year":"2021","journal-title":"J Hepatol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtct.2024.06.003","article-title":"Sinusoidal obstruction syndrome\/veno-occlusive disease after unmanipulated haploidentical hematopoietic stem cell transplantation with post-transplantation cyclophosphamide: A study on behalf of the spanish hematopoietic stem cell transplantation and cellular therapy group (GETH)","volume":"30","author":"G\u00f3mez-Centuri\u00f3n","year":"2024","journal-title":"Transplant Cell Therapy Off Publ Am Soc Transplant Cell Ther"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1038\/s41409-023-02077-2","article-title":"Current incidence, severity, and management of veno-occlusive disease\/sinusoidal obstruction syndrome in adult allogeneic HSCT recipients: an EBMT Transplant Complications Working Party study","volume":"58","author":"Ruutu","year":"2023","journal-title":"Bone Marrow Transplant"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1699219\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T06:48:38Z","timestamp":1769150918000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1699219\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,23]]},"references-count":24,"alternative-id":["10.3389\/fimmu.2025.1699219"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2025.1699219","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,23]]},"article-number":"1699219"}}